Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Fulgent Genetics Q3 2025 Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Fulgent Genetics Inc. (FLGT)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 1,468,844 | $33,195,874 | +2% | 0.01% |
| 2. | D E Shaw D. E. Shaw | 567,770 | $12,831,602 | +20% | 0.01% |
| 3. | Citadel Investment Group Ken Griffin | 371,476 | $8,395,357 | -39% | 0% |
| 4. | Point72 Asset Management Steve Cohen | 371,261 | $8,390,505 | -32% | 0.01% |
| 5. | Diametric Capital Nick Thakore | 241,622 | $5,460,657 | +43% | 2.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.96 | 100,000 | $1,596,470.00 | 348,282 | 2025-03-05 | Filing | |
| $4.95 | 8,739 | $43,239.70 | 6,579,326 | 2019-03-05 | Filing | |
| $3.59 | 10,880 | $39,032.00 | 6,570,587 | 2018-11-13 | Filing | |
| $3.36 | 10,000 | $33,610.00 | 6,559,707 | 2018-11-09 | Filing | |
| $3.60 | 1,000 | $3,604.20 | 1,000 | 2017-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.33 | 1,140 | $32,298.25 | 336,749 | 2025-12-02 | Filing | |
| $28.33 | 1,075 | $30,456.69 | 952,890 | 2025-12-02 | Filing | |
| $29.57 | 1,198 | $35,424.26 | 337,889 | 2025-11-28 | Filing | |
| $29.57 | 943 | $27,884.04 | 953,965 | 2025-11-28 | Filing | |
| $30.47 | 681 | $20,752.11 | 339,087 | 2025-11-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,260,014 | $33,100,568 | 0% | |
| 2. | 165,781 | $4,355,067 | 3.71% | |
| 3. | 83,559 | $2,195,095 | 0% | |
| 4. | 66,190 | $1,738,811 | 0.06% | |
| 5. | Imc-chicago, LlcCALL | 22,200 | $583,194 | 0% |
News See All
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Fulgent Genetics Q2 2025 Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2025 Earnings Call Transcript
Melanie Solomon: Greetings and welcome to the Fulgent Genetics, Inc. Q1 2025 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Fulgent Genetics, Inc. Q4 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Fulgent Genetics Q3 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2024 Earnings Call Transcript
Operator: Hello and welcome to the Fulgent Genetics Q2 2024 Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript
Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.33. Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript
Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $0.28, expectations were $-0.3. Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Fulgent Genetics Q3 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.